郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A2A adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase.

期刊：The Biochemical journal发表年份：2011作者：Eduard Gracia; Kamil Pérez-Capote; Estefanía Moreno; Jana Barkešová; Josefa Mallol; Carme Lluís; Rafael Franco; Antoni Cortés; Vicent Casadó; Enric I Canela
阅读更多 →

药效评价The intra-molecular activation mechanisms of the dimeric metabotropic glutamate receptor 1 differ depending on the type of G proteins.

期刊：Neuropharmacology发表年份：2011作者：Michihiro Tateyama; Yoshihiro Kubo
阅读更多 →

药效评价Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity.

期刊：Bioorganic & medicinal chemistry letters发表年份：2011作者：Alan Fulp; Katherine Bortoff; Yanan Zhang; Herbert Seltzman; Rodney Snyder; Rangan Maitra
阅读更多 →

药效评价Asymmetric synthesis and biological evaluation of N-cyclohexyl-4-[1-(2,4-dichlorophenyl)-1-(p-tolyl)methyl]piperazine-1-carboxamide as hCB1 receptor antagonists.

期刊：European journal of medicinal chemistry发表年份：2011作者：Linghuan Gao; Min Li; Tao Meng; Hongli Peng; Xin Xie; Yongliang Zhang; Yu Jin; Xin Wang; Libo Zou; Jingkang Shen
阅读更多 →